Role of portal insulin delivery in the disappearance of intravenous glucose and assessment of insulin sensitivity

Diabetes

Volumn 47, Issue 5, 1998, Pages 714-720

  Steil, Garry M ^a,c   Rebrin, Kerstin ^b   Mittelman, Steven D ^a   Bergman, Richard N ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MiniMed Inc   (United States)

^c JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG DELIVERY SYSTEM; DRUG EFFECT; GLUCAGON BLOOD LEVEL; GLUCOSE TOLERANCE TEST; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PERIPHERAL CIRCULATION; PORTAL VEIN; PRIORITY JOURNAL;

ANIMALS; BLOOD GLUCOSE; DOGS; EVALUATION STUDIES; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; PORTAL VEIN;

EID: 0031897505     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.5.714     Document Type: Article

References (24)

1. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1095
2. Madison LL, Unger RH, Rencz K: The physiologic significance of secretion of insulin into portal circulation. II. Effect of rate of administration of glucogon-free insulin on magnitude of peripheral and hepatic actions. Metabolism 9:97-108, 1960
3. Stevenson RW, Parsons JA, Alberti KGMM: Effect of intraportal and peripheral insulin on glucose turnover and recycling in diabetic dogs. Am J Physol 224:E190-E195, 1983
4. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP: The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral vein catheterization. Diabetes 30:1000-1007, 1981
5. Ishida T, Chap Z, Chou J, Lewis RM, Hartley CJ, Entman ML, Held JB: Effects of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized conscious dogs. Diabetes 33:984-990, 1984
6. Cersosimo E, Judd RL, Miles JM: Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 93:2584-2589, 1994
7. Rebrin K, Steil GM, Mittelman S, Bergman RN: Causal linkage between insulin regulation of lipolysis and liver glucose output J Clin Invest 98:741-749, 1996
8. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196, 1997
9. Ader M, Bergman RN: Peripheral effects of insulin dominate suppression of fasting hepatic glucose production. Am J Physiol 258:E1020-E1032, 1990
10. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL, Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90:1769-1777, 1992
11. Bradley DC, Poulin RA, Bergman RN: Dynamics of hepatic and peripheral insulin effects suggest common rate-limiting step in vivo. Diabetes 42:296-306, 1993
12. Finegood DT, Hramiak IM, Dupre J: A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J Clin Endocrinol Metab 70:1538-1549, 1990
13. Coates PA, Ollerton RL, Luzio SD, Ismail IS, Owens DR: Reduced sample protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model in NIDDM. Diabetes 42:1635-1641, 1993
14. Sand MF, Anderson RL, Laws A, Watanabe RM, Kades WW, Chen Y-DI, Sands RE, Savage PJ, Bergman RN: A comparison between the minimal model and the glucose clamp techniques in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43:1114-1121, 1994
15. Saad MF, Steil GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R, Jinagouda SD, Bergman RN: Effect of route of delivery and magnitude of insulinemia on insulin sensitivity measurement with the minimal model. Diabetes 46:1167-1171, 1997
16. Zambon A, Hashimoto SI, Brunzell JD: Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34:1021-1028, 1993
17. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME: Enzyme imnumoassay for intact human insulin in serum or plasma Clin Chem 39:578-582, 1993
18. Caumo A, Cobelli C: Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am J Physiol 27:E829-E841, 1993
19. De Niccolao G, Sparacino G, Cobelli C: Nonparametric input estimation in physiologic systems: problems methods and case studies. Automatica 33:851-070, 1997
20. Vicini P, Caumo A, Cobelli C: Hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity. Am J Physiol 273:E 1024-1032, 1997
21. Vicini P, Sparacino G, Caumo A, Cobelli C: Estimation of endogenous glucose production after a glucose perturbation by nonparametric stochastic deconvolution. Comp Prog Biomed 52:147-156, 1997
22. Sindelar DK, Belcom JH, Chu CA, Neal DW, Cherrington AD: A comparison of the effects of selective increases in peripheral or portal insulin on hepatic glucose production in the conscious dog. Diabetes 45:1594-1604, 1997
23. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
24. Mittelman SD, You-Yin F, Steil GM, Rebrin K, Bergman RN: The indirect effect of insulin to suppress hepatic glucose output is dominant independent of glucagon. J Clin Invest 100:3121-3130, 1997